PhD in Biomimetic Hybrid Nanoparticles for Brain Drug Delivery in

A fully funded PhD opportunity is available at The University of Manchester, with a 12-month research component at the University of Helsinki, focusing on the development of biomimetic hybrid nanoparticles for targeted brain drug delivery. The project aims to engineer cell-membrane–hybrid, ligand-tuneable nanoparticles capable of crossing the blood-brain barrier (BBB) for precise delivery of nucleic acids and other therapeutic payloads. Students will gain hands-on experience with advanced techniques such as DLS, TEM/AFM, confocal and live-cell imaging, and fluidic BBB models.

The research is designed to advance next-generation CNS therapies, gene delivery, and personalized nanomedicine. Applicants should have a background in pharmaceutical sciences, nanotechnology, biomedical or bioengineering, with experience in nanoparticle formulation, cell culture, or molecular biology considered advantageous.

The position is fully funded, including tuition and a UKRI stipend. Interested candidates should apply via the provided link and must contact Dr Christos Tapeinos and Dr Shiqi Wang by email before applying. Expressions of interest sent via LinkedIn will not be considered.